|
Volumn 53, Issue 5, 2017, Pages 842-845
|
Tumor-targeted supramolecular nanoparticles self-assembled from a ruthenium-β-cyclodextrin complex and an adamantane-functionalized peptide
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ADAMANTANE;
ARGINYLGLYCYLASPARTIC ACID;
BETA CYCLODEXTRIN;
CISPLATIN;
NANOPARTICLE;
RUTHENIUM BETA CYCLODEXTRIN;
RUTHENIUM BETA CYCLODEXTRIN ADAMANTANE APPENDED CYCLIC ARGINYLGLYCYLASPARTIC ACID;
RUTHENIUM COMPLEX;
UNCLASSIFIED DRUG;
VITRONECTIN RECEPTOR;
ANTINEOPLASTIC ACTIVITY;
ARTICLE;
CANCER CELL LINE;
CELL DEATH;
CELL VIABILITY;
CONTROLLED STUDY;
DRUG MECHANISM;
DRUG SELECTIVITY;
HUMAN;
HUMAN CELL;
SUPRAMOLECULAR CHEMISTRY;
TUMOR CELL;
|
EID: 85009216618
PISSN: 13597345
EISSN: 1364548X
Source Type: Journal
DOI: 10.1039/c6cc08296c Document Type: Article |
Times cited : (33)
|
References (31)
|